Results - Announcements
Rubicon Research Ltd share price inched up 1.38% to Rs 1740.3 after the company's net profit grew slightly 6.66% to Rs 90.43 crore, while revenue from operations improved marginally 7.87% to Rs 576.38 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, easing 5.09%. It has marginally improved by 2.18% over last one week and gained upto 2.72% in last one month while the market capitalization of Rubicon Research Ltd has improved by 8.10% and 11.90% in the same period respectively.
Profit before tax (PBT) of Rubicon Research Ltd stood at Rs 116.92 crore in Q3 FY26, expanding by 63.05% year-on-year, and rising 5.93% quarter-on-quarter. EBITDA came in at Rs 142 crore, jumping 51.49% YoY and improving 14.87% sequentially.
Total expenses posted a minor rise of 7.13% to Rs 450.34 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 175.39 crore, increasing 13.94% YoY, while employee benefits expense was at Rs 90.48 crore, inching up 5.61% YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 36.57% to Rs 1753.96 crore, while net profit soared by 83.64% to Rs 246.74 crore, compared to previous TTM. EBITDA jumped by 26830% to Rs 392.51 crore, and PBT soared 64.78% to Rs 320.53 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 205.05 crore in FY26, as against Rs 159.18 crore in FY25.
Rubicon Research Ltd rallied 172.95% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 4.80% during the same period.